Tradestie Institutional Equity Comparison Engine

JAGX vs PTN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PTN Overall Edge

PTN Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palatin Technologies, Inc. (PTN) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, JAGX trades at N/M Forward P/E with -90.2% operating margin (-58.9% YoY revenue) versus PTN at 42.9x Forward P/E and -65.7% operating margin (-80.1% YoY). In options structure, JAGX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PTN
JAGX N/M vs PTN 42.9x Fwd P/E
Growth & Margin Winner PTN
Op Margin -90.2% vs -65.7% ยท YoY -58.9% vs -80.1%
Momentum & Technical Winner PTN
1Y -77.3% vs -43.3% ยท 52W Pos 0% vs 6%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
JAGX NASDAQ
Jaguar Health, Inc.
Pharmaceutical Preparations
$0.39
-7.74% 1D
Market Cap $5.6M
1M Return -89.04%
1Y Return -77.27%
Forward P/E N/M
Unified AI Score
54.5 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 60.0
PTN US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap $11.1M
1M Return +1.74%
1Y Return -43.29%
Forward P/E 42.9x
Unified AI Score
31.5 / 100 SELL
Tech 15.0 Fund 30.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: JAGX -77.27% PTN -43.29% Spread: +33.98 pp (PTN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period JAGX Revenue PTN Revenue JAGX Op. Margin PTN Op. Margin Margin Edge
FY2019 $10M $60M -501.3% 59.3% PTN
FY2020 $10M $0M -283.9% -20007.6% JAGX
FY2021 $0M N/A -939.1% N/A JAGX
FY2022 $10M $0M -287.8% -2491.6% JAGX
FY2023 $10M $0M -351.3% -668.7% JAGX
FY2024 $10M $0M -263.8% -501.0% JAGX
FY2025 $10M N/A -398.8% N/A JAGX
FY2026 N/A $10M N/A -65.7% PTN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: JAGX (3) vs PTN (6)
Institutional Metric JAGX PTN Criterion Row Winner
Market Capitalization Scale $5.6M $11.1M Larger Scale Tie
Trailing P/E Ratio Valuation N/M 42.9x Lower Multiple PTN
Forward P/E Ratio Valuation N/M 42.9x Lower Multiple PTN
Revenue Growth (YoY) Growth -58.9% -80.1% Higher Growth JAGX
Operating Margin (TTM) Profitability -90.2% -65.7% Higher Margin PTN
Net Profit Margin Profitability -130.8% -63.5% Higher Margin PTN
Return on Equity (ROE) Capital Efficiency -548.8% -877.5% Higher ROE JAGX
52-Week Range Position Momentum 0% ($0โ€“$42) 6% ($5โ€“$31) Stronger Trend PTN
Beta / 30D Volatility Risk Regime 30.19ฮฒ ยท 228% Vol 0.87ฮฒ ยท 106% Vol Lower Realized Risk PTN
Unified Institutional Score Composite Signal 54.5 / 100 (HOLD) 31.5 / 100 (SELL) Higher Composite JAGX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full JAGX vs PTN Buy Guide
JAGX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live JAGX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PTN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PTN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither JAGX nor PTN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.